x

¿Aún no está registrado?

Cree su cuenta. Regístrese en Elsevier y obtendrá: información relevante, máxima actualización y promociones exclusivas.

Registrarme ahora
Ayuda - - Regístrese - Teléfono 902 888 740
Buscar en

Indexada en:

Index Medicus/MEDLINE, Excerpta Medica/EMBASE, SCOPUS, Science Citation Index Expanded, Journal Citation Reports/Science Edition, IBECS

Métricas

  • Factor de Impacto: 1,106(2016)
  • SCImago Journal Rank (SJR):0,314
  • Source Normalized Impact per Paper (SNIP):0,383

© Thomson Reuters, Journal Citation Reports, 2016

Endocrinol Nutr 2004;51:383-5 - DOI: 10.1016/S1575-0922(04)74631-8
Rentabilidad de las pruebas de imagen en el diagnóstico de tumores enteropancreáticos en el síndrome MEN1. A propósito de un caso
Utility Of Imaging Tests In The Diagnosis Of Enteropancreatic Tumors In Men1 Syndrome: A Case Report
P. López, E. Boix, O. Moreno, A. Picó
Sección Endocrinología y Nutrición. Hospital General Universitario de Alicante. Alicante. España
Recibido 27 junio 2003, Aceptado 27 octubre 2003
Resumen

The clinical features of MEN1 syndrome include a wide range of diseases with involvement of multiple endocrine organs. The development of genetic diagnosis, performed through study of leukocytes in peripheral blood, has allowed more precise diagnosis and strict follow-up of many asymptomatic mutation carriers. This follow-up is based on hormonal determinations and imaging tests. We describe aggressive management based on imaging techniques in a 26-year-old asymptomatic female carrier of a mutation in the MEN1 gene. The patient showed primary hyperparathyroidism, hyperprolactinemia and pancreatic tumor with suspected hepatic metastases revealed by computed tomography and magnetic resonance imaging findings but not by gammagraphic images. The clinical features, diagnosis and treatment of MEN1 are described with special emphasis on enteropancreatic tumors and imaging tests.

Palabras clave
MEN1, Mutación gen MEN1, Tumores enteropancreáticos
Key words
MEN1, Mutation in the MEN1 gene, Enteropancreatic tumors
El Texto completo solo está disponible en PDF
Biblografía
1.
M.L. Brandi,R.F. Gagel,A. Angeli,J.P. Bilezikian,P. Beck-Peccoz,C. Bordi
Guidelines for diagnosis and therapy of MEN1 type 1 and type 2
J Clin Endocrinol Metab, 86 (2001), pp. 5658-5671 http://dx.doi.org/10.1210/jcem.86.12.8070
2.
D. Veldhuis,J.A. Norton,S.A. Wells Jr,A.I. Vinik,R.B. Perry
Surgical versus Medical Management of multiple endocrine neoplasia (MEN 1) type 1
J Clin Endocrinol Metab, 82 (1997), pp. 357-364 http://dx.doi.org/10.1210/jcem.82.2.3711-1
3.
D.K. Bartsch,P. Langer,A. Wild,T. Schilling,I. Celik,M. Rothmund
Pancreaticduodenal endocrine tumors in multiple endocrine neoplasia type 1: Surgery or surveillance?
Surgery, 128 (2000), pp. 958-966 http://dx.doi.org/10.1067/msy.2000.109727
4.
R.T. Jensen
Pancreatic endocrine tumors: recent advances
Ann Oncol, 10 (1999), pp. 170-176
5.
J.H. Yim,B.A. Siegel,M.K. De Benedetti,J.A. Norton,T.C. Lairmore,H.M. Doherty
Prospective study of the utility of somatostatin-receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type 1
Surgery, 124 (1998), pp. 1037-1042
6.
N.J. Owen,S.A. Sohaib,P.D. Peppercorn,J.P. Monson,A.B. Grossman,G.M. Besser
MRI of pancreatic neuroendocrine tumours
Br J Radiol, 74 (2001), pp. 968-973 http://dx.doi.org/10.1259/bjr.74.886.740968
7.
B. Skogseid,K. Oberg,G. Akerstrom,B. Eriksson,J.E. Westling,E.T. Janson
Limited tumor involvement found at multiple endocrine neoplasia type 1 pancreatic exploration: can it be predicted by preoperative tumor localization?
World J Surg, 22 (1998), pp. 673-678
8.
C.H.J. Van Eijck,M. De Jong,W.A. Breeman,G.D. Slooter,R.L. Marquet,E.P. Krennig
Somatostatin receptor imaging and therapy of pancreatic endocrine tumors
Ann Oncol, 10 (1999), pp. S177-S181
9.
F. Gibril,J.C. Reynolds,C.C. Chen,F. Yu,S.U. Goebbel,J. Serrano
Specifity of somatostatin receptor scintigraphy: a prospective study and the effects of false positive localizations on management in patients with gastrinomas [en prensa]
J Nucl Med, (1998),
10.
D. Le Guluec,G. Cadiot,R. Lebtahi,M. Mignon
[Detection of endocrine tumors of the digestive tract
Value and limitations of scintigraphy of somatostatin of the digestive tract.] Presse Med, 25 (1996), pp. 677-682

( ! ) Notice: Undefined index: email in /var/www/html/includes_ws/librerias/html/item.php on line 1232
Call Stack
#TimeMemoryFunctionLocation
10.0003255176{main}( ).../index.php:0
20.738232850048include( '/var/www/html/elsevier/plantilla/plantilla-sidebars.php' ).../index.php:101
30.747032859240include( '/var/www/html/elsevier/plantilla/cuerpo.php' ).../plantilla-sidebars.php:15
40.791332871480include( '/var/www/html/elsevier/plantilla/cuerpo/central.php' ).../cuerpo.php:11
50.792032921184include( '/var/www/html/elsevier/contenidos/revista/item.php' ).../central.php:3
60.963032939768getAutorCorrespondenciaHTML( ).../item.php:320

( ! ) Notice: Undefined index: email in /var/www/html/includes_ws/librerias/html/item.php on line 1232
Call Stack
#TimeMemoryFunctionLocation
10.0003255176{main}( ).../index.php:0
20.738232850048include( '/var/www/html/elsevier/plantilla/plantilla-sidebars.php' ).../index.php:101
30.747032859240include( '/var/www/html/elsevier/plantilla/cuerpo.php' ).../plantilla-sidebars.php:15
40.791332871480include( '/var/www/html/elsevier/plantilla/cuerpo/central.php' ).../cuerpo.php:11
50.792032921184include( '/var/www/html/elsevier/contenidos/revista/item.php' ).../central.php:3
60.963032939768getAutorCorrespondenciaHTML( ).../item.php:320
Correspondencia: Dr. P. López. Sección Endocrinología y Nutrición. Hospital General Universitario de Alicante. Pintor Baeza, s/n. 03010 Alicante. España. (P. López )
Copyright © 2004. Sociedad Española de Endocrinología y Nutrición